Intestinal Obstruction in the Newborn

1994 ◽  
Vol 15 (9) ◽  
pp. 338-347 ◽  
Author(s):  
Arthur J. Ross

Obstruction of an infant's gastrointestinal (GI) tract can occur anywhere from the esophagus to the anus. For purposes of this review, the newborn infant will be defined as an infant from birth to 30 days of age. Both congenital and acquired obstructions will be addressed. In each instance, the epidemiology, pathogenesis, clinical aspects, and management of the disorder will be considered. Esophageal Atresia EPIDEMIOLOGY AND PATHOGENESIS Esophageal atresia, or interruption of the esophagus, generally occurs in association with a tracheoesophageal fistula (EA - TEF). The most common anatomic arrangement is a blind proximal esophageal pouch that has a distal tracheoesophageal fistula (Figure 1). This is seen in 85% to 90% of infants who have this anomaly. Seen less commonly is pure esophageal atresia that does not have a tracheoesophageal fistula and tracheoesophageal fistula that does not have an esophageal atresia (H-type tracheoesophageal fistula). These latter two conditions occur in approximately 10% of newborns who have these types of anomalies. Other anatomic arrangements, such as an esophageal atresia that has a fistula between the upper pouch and trachea or esophageal atresia that has a fistula to both pouches, are seen in only a tiny fraction of these infants. EA - TEF occurs in approximately 1 in 4000 live births.

Author(s):  
Catherine P. Seipel ◽  
Titilopemi A. O. Aina

Tracheoesophageal fistula (TEF) with esophageal atresia (EA) is a congenital malformation occurring in approximately 1:4,000 live births. TEF/EA is characterized by disrupted continuity of the esophagus. There are five distinct types, but the most common is EA with a distal TEF. Most cases are diagnosed postnatally after an inability to pass a nasogastric tube (NGT), with subsequent radiographic imaging finding the NGT coiled within the esophageal pouch. The anesthetic management of TEF/EA repair can be complicated by the presence of cardiac, renal, and vertebral anomalies. Additionally, ventilation can be challenging, and care must be taken to minimize insufflation of the stomach through the fistula. Postoperative analgesia should include consideration of intravenous opioids, nonopioid adjunct medications, and regional and neuraxial techniques.


Author(s):  
Ajay D’Mello ◽  
Vidya T. Raman

A tracheoesophageal fistula (TEF) is a communication that is congenital or acquired between the trachea and esophagus. The reported incidence of TEF or esophageal atresia (EA) is roughly one to two per 5,000 live births. The first successful surgery for TEF was in 1939. Presently, owing to progress in surgical techniques, neonatal intensive care, and neonatal anesthesia, the majority of neonates with a TEF/EA who do not have severe associated congenital anomalies are expected to have satisfactory outcomes. Coexisting congenital abnormalities occur in 30 to 50% of patients with TEF/EA. Congenital anomalies are more common in patients with isolated esophageal atresia (65%) compared with isolated tracheoesophageal fistula (10%).


PEDIATRICS ◽  
1974 ◽  
Vol 54 (5) ◽  
pp. 558-564
Author(s):  
C. Everett Koop ◽  
Louise Schnaufer ◽  
A. Michael Broennle

The survival of infants with esophageal atresia with or without tracheoesophageal fistula has been analyzed over a 24-year period divided into three eras of five years each depending upon the quality of intensive care available and the most recent nine years' experience. Early diagnosis and skillful transportation to definitive surgical care are essential. Diagnosis by x-ray with a coiled catheter in the upper esophageal pouch without the use of radiopaque material is beneficially reflected in a decreased incidence of pneumonia and a reduced mortality. The skills of anesthesia carried over into close supervision of respiratory care postoperatively have further increased the salvage rate of these infants. As surgical technical problems have been overcome, the percentage of deaths due to associated major anomalies and pneumonia and/or sepsis has increased. Invasive techniques for diagnosis, for monitoring, and for treatment do not seem to be responsible for the sepsis. In the most recent experience with 134 patients over nine years the overall survival was 66%; full-term infants had a 70% survival while the survival rate for prematures was 52%. In full-term infants without pneumonia and without a major associated congenital anomaly, the survival rate was 100% (44 patients). Clearly the target for improvement in survival is the prevention of and the improvement in treatment of pneumonia and sepsis.


1980 ◽  
Vol 15 (6) ◽  
pp. 857-862 ◽  
Author(s):  
Stephen G. Jolley ◽  
Dale G. Johnson ◽  
Charles C. Roberts ◽  
John J. Herbst ◽  
Michael E. Matlak ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document